SSIISSIIHealthcare · Medical Devices

SSII Stock Forecast: SS Innovations International, Inc. Price Predictions for 2026-2027

Last close, 11 Sept 2026
$3.31

The 1 Wall Street analysts covering SS Innovations International, Inc. hold a median 12-month price target of $7 — +111.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 21 of 100 as at 12 Sept 2026 — in the weakest quartile. The Street sees upside; the factor read is a caution. That gap is the story on this page.

Market cap
$663.3M
Ticker Nerd rank
21 / 100
Median analyst target
$7.00
Analysts covering
1
Revenue$13.9M+39.4% y/y
Operating income−$2.3M
Net income−$2.7M
Free cash flow−$4.4M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Ticker Nerd rank

SSII stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SS Innovations International, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 12 Sept 2026
21 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
66
Revisions
61
Size
50
Growth
46
Value
44
Accruals
17
Issuance
15
Momentum
14
Volatility
10

Quality (66): The business earns solid, repeatable profits on what it owns.

Volatility (10): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SSII stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SSII, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says1 analysts
1 Buy0 Hold0 Sell
Low $7.00Median $7.00High $7.00

The green dot is the last close — the median target sits +111.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
3 June 2026LUCID CAPITAL MARKETSInitiatesBuy$7.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SSII appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

SSII analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
0
Analysts cutting
0
Fundamentals

SS Innovations International, Inc. (SSII) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−55.0×

Cheaper than 99% of US stocks

Price / sales
12.7×

Cheaper than 12% of US stocks

Price / book
12.2×

Cheaper than 8% of US stocks

EV / EBITDA
−92.8×

Cheaper than 96% of US stocks

Growth & margins
Revenue growth (YoY)
39.4%

Higher than 83% of US stocks

Earnings growth (YoY)
39.4%

Higher than 71% of US stocks

Gross margin
50.9%

Higher than 63% of US stocks

Operating margin
−16.3%

Higher than 23% of US stocks

Net margin
−23.7%

Higher than 15% of US stocks

Returns & dividend
Return on equity
−26.1%

Higher than 29% of US stocks

Return on assets
−6.3%

Higher than 30% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

SS Innovations International, Inc. (SSII) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • SS Innovations International, Inc. has a market value of $663.3M and an enterprise value of $667.5M.

  • Revenue in the twelve months to 30 June 2026: $52.4M. The latest quarter grew 39.4% year on year.

  • Net income over the same four quarters: −$12.4M, a −23.7% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.06.

  • Free cash flow in the twelve months to 30 June 2026: −$18.2M.

  • Shares outstanding: 200.2M.

  • Trailing P/E: −55.0×; forward P/E: −55.2× — the forward figure prices analyst consensus estimates, not reported earnings.

  • SS Innovations International, Inc. employs 483 people $108K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 12 Sept 2026

Data provided by Twelve Data

Peers

SSII vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
SSIISS Innovations International, Inc.$663.3M
21
CTKBCytek Biosciences, Inc.$595.3M
64
BBNXBeta Bionics, Inc.$729.5M
40
KIDSOrthoPediatrics Corp.$553.2M
65
DCTHDelcath Systems, Inc.$549.2M
96
VREXVarex Imaging Corp.$773.8M
80
QDELQuidelOrtho Corp.$803.3M
35

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own SS Innovations International, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SSII news & analysis

SS Innovations Provides Update on Continuing Progress and Milestones

GlobeNewsWire · 10 Sept 2026positive

SS Innovations International, Inc. provided an update on its continuing progress and milestones, highlighting advances in global expansion, pediatric robotic surgery, telesurgery, and growing installations, procedures, and utilization of its SSi Mantra surgical robotic technology.

Why it matters — SSII watchers would care because the update signals continued operational momentum across global expansion, pediatric surgery, and growing adoption of the SSi Mantra system.

SS Innovations Reports Second Quarter 2026 Financial Results

GlobeNewsWire · 13 Aug 2026positive

SS Innovations International reported its second quarter 2026 financial results, posting record quarterly revenue. The revenue growth was driven by continued strong sales of its SSi Mantra surgical robotic units.

Why it matters — Record revenue and sustained growth in SSi Mantra unit sales signal strengthening commercial performance for SSII's core product offering.

FAQ

Frequently asked questions about SSII stock

What is the SSII stock price forecast for 2026-2027?

The 1 Wall Street analysts covering SS Innovations International, Inc. have a median 12-month price target of $7, with estimates ranging from $7 to $7. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SSII stock a buy right now?

Of the 1 analysts covering SS Innovations International, Inc., 1 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SS Innovations International, Inc. 21 out of 100 across roughly 4,600 US stocks as at 12 Sept 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SSII?

As at 12 Sept 2026, SS Innovations International, Inc. ranks 21 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (66 of 100).

Will SSII stock go up?

No one can know that. What the data says: the median 12-month target from 1 analysts implies +111.5% from the last close, and Ticker Nerd's factor model ranks SS Innovations International, Inc. 21 out of 100 as at 12 Sept 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SSII stock forecast for 2030?

No analyst covering SS Innovations International, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SSII are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $7 over the next 12 months.

What does SS Innovations International, Inc. do?

SS Innovations International, Inc. is a medical technology company focused on surgical robotics and related instruments.

What is the latest news on SSII?

The most recent item we track (GlobeNewsWire, 10 Sept 2026): "SS Innovations Provides Update on Continuing Progress and Milestones". SS Innovations International, Inc. provided an update on its continuing progress and milestones, highlighting advances in global expansion, pediatric robotic surgery, telesurgery, and growing installations, procedures, and utilization of its SSi Mantra surgical robotic technology.

Company

About SS Innovations International, Inc.

SS Innovations International, Inc. is a medical technology company focused on surgical robotics and related instruments. The company develops, manufactures, and commercializes robotic-assisted surgery systems designed to support minimally invasive procedures across multiple specialties, including cardiac, urology, gynecology, general surgery, and thoracic care. Its product portfolio centers on the SSi Mantra surgical robotic system and the SSi Mudra line of surgical instruments, which together form an integrated platform for surgeons and hospitals. SS Innovations International serves healthcare providers in India and international markets, where its solutions are used to expand access to advanced robotic surgery and support a broad range of clinical applications. The company operates as a commercial-stage business within the medical devices and healthcare technology sectors.

CEO Dr. Sudhir Prem Srivastava M.D. · 483 employees · India · https://ssinnovations.com